文献速递炎症性肠病消化内镜消化道肿瘤与早癌

炎症性肠病监测:白光内镜分段复查与染料染色内镜对比——多臂随机对照试验(HELIOS)

Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy - a multi-arm randomised controlled trial (HELIOS).
PubMed 文献 · Gut · 2025-03-06

这项多中心随机对照试验将563例炎症性肠病监测患者按2:2:1随机分为高清白光内镜分段复查组、高清染色内镜组和单次高清白光内镜组。分段复查组肿瘤检出率为10.3%,染色内镜组为13.1%,证实非劣效;单次白光组为6.1%,低于分段复查组但未达统计学显著。

要点

  • 高清白光内镜分段复查对结直肠肿瘤检出非劣效于高清染色内镜。
  • 分段复查组每10分钟退镜时间检出肿瘤数与染色内镜组相似。
  • 单次高清白光内镜肿瘤检出率低于分段复查组但差异未达统计学显著。

核心结论

  • 高清白光内镜分段复查对炎症性肠病患者结直肠肿瘤检出非劣效于高清染色内镜。
  • 高清染色内镜的获益可能源于更长的退镜时间而非增强对比。
  • 分段复查本身并未较单次高清白光内镜显著提高肿瘤检出率。

研究设计与样本

  • 多中心随机对照试验,纳入年龄≥18岁、无活动性疾病并计划接受内镜监测的炎症性肠病患者。
  • 患者按2:2:1随机分配至高清白光内镜分段复查组、高清染色内镜组或单次高清白光内镜组。
  • 主要结局为结直肠肿瘤检出率,假设分段复查与染色内镜非劣效margin为10%,分段复查优于单次白光内镜,所需样本量为566例。
  • 按方案分析共563例患者。

主要发现

  • 高清白光内镜分段复查组结直肠肿瘤检出率为10.3%(n=24/234),高清染色内镜组为13.1%(n=28/214)。
  • 分段复查对染色内镜的非劣效性成立(Δ-2.8%,95%CI下限-7.8,p<0.01)。
  • 每10分钟退镜时间检出结直肠肿瘤数在分段复查组与染色内镜组相似(0.062 vs 0.058,p=0.83)。
  • 单次高清白光内镜组结直肠肿瘤检出率为6.1%(n=7/115),低于分段复查组但未达统计学显著(Δ4.1%,95%CI -2.2:9.6%,p=0.19)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear if the increased colorectal neoplasia detection rate in inflammatory bowel disease (IBD) by high-definition (HD) dye-based chromoendoscopy compared with HD white-light endoscopy is due to enhanced contrast or increased inspection times. Longer withdrawal times may yield similar neoplasia detection rates as found by HD chromoendoscopy. OBJECTIVE: To compare colorectal neoplasia detection rates for HD white-light endoscopy with segmental re-inspection and HD chromoendoscopy, using single-pass HD white-light endoscopy as an additional control group. DESIGN: In a multicentre, randomised controlled trial, IBD patients aged ≥18 years without active disease and scheduled for endoscopic surveillance were included. Patients were 2:2:1 randomised to HD white-light endoscopy with segmental re-inspection of each colonic segment (double pass), HD chromoendoscopy or single-pass HD white-light endoscopy. The primary outcome was colorectal neoplasia detection rate. Assuming equal colorectal neoplasia rates (non-inferiority margin of 10%) between segmental re-inspection and chromoendoscopy and superiority of segmental re-inspection vs single-pass HD white-light endoscopy, a sample size of 566 patients was required. RESULTS: In total, 563 patients were analysed per-protocol. Colorectal neoplasia detection rates were 10.3% (n=24/234) for HD white-light endoscopy with segmental re-inspection and 13.1% (n=28/214) for HD chromoendoscopy. This confirmed non-inferiority to HD chromoendoscopy (Δ-2.8%, lower limit 95% CI -7.8, p<0.01). In addition, the number of detected colorectal neoplasia per 10 min of withdrawal time was similar between HD white-light endoscopy with segmental re-inspection and HD chromoendoscopy (0.062 vs 0.058, p=0.83). Single-pass HD white-light endoscopy yielded a lower colorectal neoplasia rate (6.1%; n=7/115) than segmental re-inspection but this was not statistically significant (Δ4.1%, 95% CI -2.2:9.6%, p=0.19). CONCLUSIONS: HD white-light endoscopy with segmental re-inspection was non-inferior to HD chromoendoscopy for colorectal neoplasia detection in IBD patients. It can therefore be assumed that the benefit of HD chromoendoscopy may be explained by the longer withdrawal time and not necessarily the enhanced contrast. However, re-inspection per se did not lead to a significantly higher colorectal neoplasia rate than single-pass HD white-light endoscopy alone.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Te Groen M, Wijnands AM, den Broeder N, et al. Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy - a multi-arm randomised controlled trial (HELIOS). Gut. 2025. PMID: 39819862. doi:10.1136/gutjnl-2024-333446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。